Samsung Biologics, Foreign Investors Net Sell 2,250 Shares... Stock Price Down 2.1%
Samsung Biologics ranked among the top searched stocks on 11 days in the past month.
As of 12:32 PM on the 16th, Samsung Biologics is trading at 825,000 KRW, up 2.1% from the previous day. This represents a 37.5% increase compared to May 19. Samsung Biologics is known as the holding company for Samsung Group's bio business.
Today, foreigners have net sold 2,250 shares of Samsung Biologics, and institutions have net sold 1,000 shares, according to provisional data. Over the past five days, individual investors have net sold 97,260 shares, while foreigners and institutions have net bought 66,704 shares and 16,919 shares, respectively.
On June 15, Samsung Biologics was a market topic with the headline "Record High... Five Consecutive Days of Gains."
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
